BIOLIFE SOLUTIONS INCBLFSEarnings & Financial Report
Nasdaq
NextApr 8, 2026
BLFS Q3 2025 Key Financial Metrics
Revenue
$28.1M
Gross Profit
N/A
Operating Profit
$-89.0K
Net Profit
$621.0K
Gross Margin
N/A
Operating Margin
-0.3%
Net Margin
2.2%
YoY Growth
-8.2%
EPS
$0.01
Financial Flow
BIOLIFE SOLUTIONS INC Q3 2025 Financial Summary
BIOLIFE SOLUTIONS INC reported revenue of $28.1M for Q3 2025, with a net profit of $621.0K (2.2% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $28.1M |
|---|---|
| Net Profit | $621.0K |
| Gross Margin | N/A |
| Operating Margin | -0.3% |
| Report Period | Q3 2025 |
BIOLIFE SOLUTIONS INC Annual Revenue by Year
BIOLIFE SOLUTIONS INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $82.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $82.3M |
| 2023 | $143.3M |
| 2022 | $161.8M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.7M | $31.7M | $28.3M | $30.6M | $-8.4M | $23.9M | $25.4M | $28.1M |
| YoY Growth | -26.0% | -15.9% | -28.3% | -8.3% | -125.6% | -24.5% | -10.3% | -8.2% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $412.7M | $401.6M | $375.0M | $381.7M | $399.5M | $395.1M | $387.2M | $392.1M |
| Liabilities | $75.1M | $68.2M | $53.5M | $56.2M | $50.6M | $42.5M | $40.1M | $38.3M |
| Equity | $337.7M | $333.4M | $321.4M | $325.5M | $348.9M | $352.6M | $347.2M | $353.7M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $2.3M | $-4.5M | $6.5M | $4.8M | $1.6M | $1.7M | $7.4M | $6.1M |